Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251826 | SCV000309660 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000726086 | SCV000341845 | uncertain significance | not provided | 2016-05-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000251826 | SCV000527733 | likely benign | not specified | 2018-03-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000251826 | SCV000594486 | likely benign | not specified | 2016-01-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001086817 | SCV000649632 | likely benign | Qualitative or quantitative defects of dysferlin | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001271794 | SCV001453234 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-04-23 | no assertion criteria provided | clinical testing |